A major study has confirmed earlier findings that drugs used in fertility treatment are not associated with a higher risk of ovarian cancer, according to an article in the New York Times. Although the study did not rule out any link with cancer -- in particularly, it echoed it offered reassurance to women alarmed by earlier research linking a rare but often deadly cancer to certain fertility medications.
From the article:
“The message to give clinicians and patients is that over all these
data provide further evidence that fertility drugs do not increase the
risk of ovarian cancer to any great extent,” said Allan Jensen, an
assistant professor of cancer epidemiology at the Danish Cancer Society
and the first author of the paper. The senior author was Susanne Krüger
Kjaer.
Dr. Jensen added, “You should always balance a possible
small increase in ovarian cancer risk with the physical and
psychological benefits of pregnancy made possible only by use of these drugs.”
The study, one of the largest ever to address the issue, looked at more than 50,000 patients seeking fertility treatment in Denmark between 1963 and 1998.
More By This Author:
Little Girl with Bowel Disease Kept Alive on Donated Breastmilk
They Say: More Abuse, Neglect Among Bottle-Feeding Moms
Does Obama's Election Mean Black Kids Now Have "No Excuses"?
Man Kills Family, Self, After Layoffs
